MAXIMUS (MMS) Announces US HHS Cancelled Solicitation For Contract
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MMS Hot Sheet
Price: $63.44 +0.09%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: 0.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: 0.0%
Join SI Premium – FREE
On November 26, 2024 MAXIMUS (NYSE: MMS). issued a press release announcing that it was notified by the U.S. Department of Health and Human Services that the solicitation for the Contact Center Operations (CCO) 1-800-MEDICARE and Federal Marketplace contract has been cancelled and the project will not be re-solicited at this time. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
- AI-powered cyber threats light a fire under cybersecurity stocks
- Lycia Therapeutics reportedly allocates zero shares to half of investors
Create E-mail Alert Related Categories
8K, Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
